New global lab network will compare vaccines head-to-head
LONDON: A major non-profit health emergencies group has set up a global laboratory network to assess data from potential Covid-19 vaccines, allowing scientists and drugmakers...
CureVac
CureVac plans global late-stage Covid-19 vaccine trial in fourth quarter
Germany‘s CureVac NV said on Tuesday it has started a mid-stage study testing its experimental coronavirus vaccine and plans to begin a decisive global trial...
BioNTech, CureVac bag $745M in German funding for COVID-19 vaccine hopefuls
Two German biotechs, BioNTech and CureVac, have been at the cutting edge of the hunt for a COVID-19 vaccine—a time-consuming and costly process. In order...